rs12212247

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_007045.4(CEP43):​c.103-9T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000687 in 1,454,572 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

CEP43
NM_007045.4 intron

Scores

2
Splicing: ADA: 0.005686
2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.229

Publications

21 publications found
Variant links:
Genes affected
CEP43 (HGNC:17012): (centrosomal protein 43) This gene encodes a largely hydrophilic centrosomal protein that is required for anchoring microtubules to subcellular structures. A t(6;8)(q27;p11) chromosomal translocation, fusing this gene and the fibroblast growth factor receptor 1 (FGFR1) gene, has been found in cases of myeloproliferative disorder. The resulting chimeric protein contains the N-terminal leucine-rich region of this encoded protein fused to the catalytic domain of FGFR1. Alterations in this gene may also be associated with Crohn's disease, Graves' disease, and vitiligo. Alternatively spliced transcript variants that encode different proteins have been identified. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP43NM_007045.4 linkc.103-9T>A intron_variant Intron 1 of 12 ENST00000366847.9 NP_008976.1 O95684-1
CEP43NM_194429.3 linkc.103-9T>A intron_variant Intron 1 of 11 NP_919410.1 O95684-2
CEP43NM_001278690.2 linkc.103-9T>A intron_variant Intron 1 of 10 NP_001265619.1 A0A087WV25B4DH64

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP43ENST00000366847.9 linkc.103-9T>A intron_variant Intron 1 of 12 1 NM_007045.4 ENSP00000355812.3 O95684-1
ENSG00000272980ENST00000705249.1 linkc.103-9T>A intron_variant Intron 1 of 12 ENSP00000516101.1 A0A994J5H4

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.87e-7
AC:
1
AN:
1454572
Hom.:
0
Cov.:
29
AF XY:
0.00
AC XY:
0
AN XY:
724124
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33254
American (AMR)
AF:
0.00
AC:
0
AN:
44322
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26078
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39586
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85762
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53286
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5742
European-Non Finnish (NFE)
AF:
9.04e-7
AC:
1
AN:
1106370
Other (OTH)
AF:
0.00
AC:
0
AN:
60172
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.675
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
10614

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
3.7
DANN
Benign
0.78
PhyloP100
0.23
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0057
dbscSNV1_RF
Benign
0.20
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12212247; hg19: chr6-167413539; API